HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that with the number of people diagnosed with diabetes in the United States doubling over the past 15 years, insurers and employers are exploring options to better manage the chronic disease. According to recent reports from HealthLeaders-InterStudy, current and proposed disease management initiatives seek to better control expenses by preventing costly diabetes-related complications such as blindness and amputation.

The recent Tennessee Health Plan Analysis finds that as of January 2009, CoverTN, Tennessee's three-share limited benefit health coverage program for low-income workers in small businesses, will eliminate limits on insulin, diabetic supplies and oral diabetic medicines and decrease copays on those items.

"The prevalence of diabetes is greater in Tennessee than the national average," said Don Mooradian, analyst with HealthLeaders-InterStudy. "By reducing the cost of medications associated with diabetes management in the CoverTN program, the state hopes to decrease barriers to care and prevent costly disease-related complications. In fact, the state is looking across its government-sponsored plans to offer consistent diabetes-related care benefits."

In Virginia, employers and insurers are looking at a new study from the Virginia Business Coalition on Health to inform their development of strategies to improve diabetes management and control costs. The study pinpoints the diabetes incidence by geographic area and quantifies how money is spent on treating diabetes in the state, reporting on 2007 patient demographics, use of services, hospital and physician charges and pharmacotherapy in five Virginia markets -- Danville, Lynchburg, Norfolk, Richmond/Petersburg and Roanoke -- as compared to the state and the nation. According to the recent Mid-Atlantic Health Plan Analysis, the report also identifies opportunities for patient education.

"Every major insurer in Virginia has some form of a diabetes management program, but as the incidence of diabetes continues to increase, employers are now looking closely at how much they've been spending on treating diabetes," said Jan Shuxteau, analyst with HealthLeaders-InterStudy. "Information about patient demographics, services provided and costs will help businesses analyze their health insurance policies. While employers don't often review specific disease coverage when selecting health plans, quantifying the incidence and cost of diabetes might move them in this direction."

Why Pharmaceutical Companies Need Health Plan Analysis

Health Plan Analysis identifies key health plan trends, allowing pharmaceutical companies to create comprehensive strategic plans and sales strategies at state and local levels. Updated quarterly, Health Plan Analysis provides a detailed look at plan design and financials, as well as information about mergers, legislation and other influencers driving healthcare in a particular region.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit http://www.hl-isy.com/.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:    Lisa Osgood                   Elizabeth Marshall   HealthLeaders-InterStudy      Decision Resources, Inc.   781-296-2606                  781-296-2563   losgood@hl-isy.com            emarshall@dresources.com 

First Call Analyst:
FCMN Contact:

SOURCE: HealthLeaders-InterStudy

CONTACT: Lisa Osgood of HealthLeaders-InterStudy, +1-781-296-2606,
losgood@hl-isy.com; or Elizabeth Marshall of Decision Resources, Inc.,
+1-781-296-2563, emarshall@dresources.com

Florida and California Represent Equivalent Areas of Opportunity in the Alzheimer's Disease Drug Market

View Now